EP 1622684 A4 20070725 - COMPOSITIONS AND METHODS RELATING TO NOVEL COMPOUNDS AND TARGETS THEREOF
Title (en)
COMPOSITIONS AND METHODS RELATING TO NOVEL COMPOUNDS AND TARGETS THEREOF
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN FÜR NEUE VERBINDUNGEN UND IHRE TARGETS
Title (fr)
COMPOSITIONS ET PROCEDES DE RECHERCHE DE NOUVEAUX COMPOSES ET LEURS CIBLES
Publication
Application
Priority
- US 2004013455 W 20040430
- US 42721103 A 20030501
- US 42721203 A 20030501
- US 63411403 A 20030804
- US 79553504 A 20040308
Abstract (en)
[origin: WO2005004988A2] The present invention relates to novel chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides benzodiazepine derivatives and methods of using benzodiazepine derivatives as therapeutic agents to treat a number of conditions associated with the faulty regulation of the processes of programmed cell death, autoimmunity, inflammation, and hyperproliferation, and the like.
IPC 8 full level
A61K 31/5513 (2006.01); A61K 45/00 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61P 37/02 (2006.01); A61P 37/06 (2006.01); C12N 5/02 (2006.01); C12N 7/01 (2006.01); C12Q 1/42 (2006.01); G01N 33/50 (2006.01)
IPC 8 main group level
A61P (2006.01)
CPC (source: EP)
A61K 31/5513 (2013.01); A61P 1/00 (2017.12); A61P 35/00 (2017.12); A61P 37/00 (2017.12); A61P 37/02 (2017.12); A61P 37/06 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12); C12Q 1/42 (2013.01); G01N 33/5079 (2013.01); G01N 2510/00 (2013.01)
Citation (search report)
- [X] WO 03015703 A2 20030227 - UNIV MICHIGAN [US], et al
- [PX] US 2003119029 A1 20030626 - GLICK GARY D [US], et al
- [X] US 2001016583 A1 20010823 - GLICK GARY D [US], et al
- [PX] EP 1398033 A2 20040317 - UNIV MICHIGAN [US]
- [X] BLATT N B ET AL: "Benzodiazepine-induced superoxide signals B cell apoptosis: mechanistic insigfht and potential therapeutic utility", THE JOURNAL OF CLINICAL INVESTIGATION, vol. 10, no. 8, October 2002 (2002-10-01), pages 1123 - 1132, XP002422965
- See references of WO 2005004988A2
Citation (examination)
- JOHNSON K.M. ET AL.: "Mechanistic basis for therapeutic targeting of the mitochondrial F1F0-ATPase", ACS CHEMICAL BIOLOGY, vol. 1, no. 5, June 2006 (2006-06-01), UNITED STATES, pages 304 - 308, XP007906563
- BASTIAN E.D. ET AL: "Casein interference in bovine plasmin assays using a synthetic substrate", JOURNAL OF DAIRY SCIENCE, vol. 74, no. 12, December 1991 (1991-12-01), UNITED STATES, pages 4119 - 4124, XP007906550
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005004988 A2 20050120; WO 2005004988 A3 20060223; AU 2004255153 A1 20050120; AU 2004255153 B2 20071122; CA 2524394 A1 20050120; CA 2524394 C 20110712; EP 1622684 A2 20060208; EP 1622684 A4 20070725; JP 2007500212 A 20070111; MX PA05011741 A 20060512
DOCDB simple family (application)
US 2004013455 W 20040430; AU 2004255153 A 20040430; CA 2524394 A 20040430; EP 04775923 A 20040430; JP 2006532522 A 20040430; MX PA05011741 A 20040430